PXIIX
Price
$22.04
Change
+$0.12 (+0.55%)
Updated
Nov 12 closing price
Net Assets
166.54M
VIVAX
Price
$73.91
Change
+$0.39 (+0.53%)
Updated
Nov 12 closing price
Net Assets
207.95B
Interact to see
Advertisement

PXIIX vs VIVAX

Header iconPXIIX vs VIVAX Comparison
Open Charts PXIIX vs VIVAXBanner chart's image
Virtus KAR Equity Income I
Price$22.04
Change+$0.12 (+0.55%)
VolumeN/A
Net Assets166.54M
Vanguard Value Index I
Price$73.91
Change+$0.39 (+0.53%)
VolumeN/A
Net Assets207.95B
PXIIX vs VIVAX Comparison Chart in %
View a ticker or compare two or three
VS
PXIIX vs. VIVAX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PXIIX is a StrongBuy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 208B vs. PXIIX (167M). PXIIX pays higher dividends than VIVAX: PXIIX (4.33) vs VIVAX (1.98). PXIIX was incepted earlier than VIVAX: PXIIX (18 years) vs VIVAX (33 years). PXIIX (1.11) is less costly to investors than VIVAX (0.17). PXIIX is a more actively managed with annual turnover of: 17.00 vs. VIVAX (9.00). VIVAX has a lower initial minimum investment than PXIIX: VIVAX (3000) vs PXIIX (100000). PXIIX (7.02) and VIVAX (6.68) have marching annual gain over last year. VIVAX return over 5 years is better than : 66.34 vs. PXIIX (2.08).
PXIIXVIVAXPXIIX / VIVAX
Total Expense Ratio0.950.17559%
Annual Report Gross Expense Ratio1.110.17653%
Fund Existence18 years33 years-
Gain YTD10.89011.96591%
Front LoadN/AN/A-
Min. Initial Investment10000030003,333%
Min. Initial Investment IRAN/AN/A-
Net Assets167M208B0%
Annual Yield % from dividends4.331.98219%
Returns for 1 year7.026.68105%
Returns for 3 years20.8533.4962%
Returns for 5 years2.0866.343%
Returns for 10 years51.04135.0038%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMORX46.170.25
+0.54%
Patient Opportunity R
NUGIX37.830.15
+0.40%
Nuveen Global Dividend Growth I
VNVCX22.500.06
+0.27%
Natixis Vaughan Nelson Mid Cap C
VADCX72.690.17
+0.23%
Invesco Equally-Wtd S&P 500 C
IHSSX27.75-0.12
-0.43%
Hartford Small Company R4